Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
BTD is just around the corner..........
Agree!!! Thanks WILD!!!
Leo. We know what your up to! BP got your tongue and forcing SEC docs to be filed?!?!? ;)
Go IPIX!!!
Right. B-OM topline was not 8-k’d. So why a subset group of patients in that trial.
So you are in the opinion, Leo 8-K’d to possible reach a wider audience?
Why 8k now? Interesting........
If anyone is confused. Slide 10 is where you want to go.
Maximize Value of Current Assets = dr B anchoring philosophy over the past couple years. More trials and poc for more indications.
Capture ROI through Partnerships = this piece is out because that is where we are.
Select Key Programs for Continued Internal Development. = this tells me that we are going to partner some drugs for big coin and take a select few in-house and keep going while we collect royalties and milestones in the others.
Jmo
BTD is coming. And the markets do realize BTD offers some great benefits in drug development. IPIX is on a roll
Where are you guys seeing these weekly data sets for the types of Chemo? I don’t see any data sets in this PR?
Watched that ask get smothered into the zip codes all while being below the bid. Haha. All good.
Better data released today so in the end we will make fist fulls of cash
Today may have been an Aspire day ;)
Thank you for your input and docs
I assume as they are finalizing the Clinical Study Report, they are uncovering more data to share with us?
Plenty! Please explain this new data for us common folk!
Hand is raised! High. Leo would be PR ing much more imo and using those PRs to offset aspire. But instead......dead silent and only 5 PRs in all of 2018.
Something is definitely up
Trust me. There are many more interested in K than Am thinks.
K is a powerhouse
The LAST thing I want to do is set unreal expectations. However, a reason one invests in bio is for a chance to make great returns on drugs that make big differences.
Prurisol is the IPIX dark horse.
Seeing that graph has to have all current investors intrigued, because look at the 100 and 50 mg arms. Basically the same as placebo. And then the jump from 200 starts to show a huge difference in comparison.
WHAT IF THE 200 was the beginning of the efficacious dose. What if 300 and 400 are the same in comparing 200 as the 50 and 300 is the 200....another huge leap in efficacy.
That’s what I’m hoping. 200 was the lowest dose to see the start of efficacy.
It’s possible and no one can deny that.
No matter what is “really” going on in closed doors at IPIX...it will be interesting to see these P results. And if good or really good to see the fire it may light under some of these CDAs.
I am dreaming of a scenario that we get back over 40% PASI 75. That would be like a wildfire in 75mph winds. IMO.
It’s possible too based on pre-clinical and the overview look of the phase 2a with such a dramatic increase in efficacy from 100 to 200mg dosing. What if that doubles at 300 and maybe again doubles at 400. What if P cures psoriasis like in the mouse models? Anything is possible and I’m excited to see.
Godspeed.
Prediction: The story will continue to play out. They are in the final phase of their plot. Enough have covered and the affiliates have collected enough on the long term take down. It is about time. I spotted the sun and therefore it shall rise. It’s been a long strange trip, but the pump is on.
Time for the filthy and rich to become richer...all on making history for IPIX.
I believe it is time for the correction.
Go ahead dud. It’s time.
Things are tight. Everyone is on pins and needles waiting for confirmation of turn around for flippers. I really think Aspire is done being tapped so I do believe it will not be easy to get cheap shares and flip anymore.
Cash? Lol. We are basically waiting to see the primary outcome. What PASI 75 score will it bring.
Otezla brought around 33% PASI 75
Otezla is blockbuster drug.
That is our bar. However P brings a much safer drug and the 505 designation. That means possible extra 3-5 years exclusivity. And a possible quicker phase 3 and maybe only one.
Good opinion. I could see that as well. I believe that these p results will dictate the direction and future of IPIX. Jmo
I’m seeing bid higher than ask?
IMO of course. However, I’ve been here long enough and am perceptive to understand exactly what is going on.
Agree. Aspire is no longer needed. We will all find out soon.
Exactly. Why does IPIX continue to structure trials in the most stringent fashion? And continue to succeed!
No. That is just OS
Yes. Just a hunch. We will find out on the next news event. IMO.
Good luck on the trades.
I think they are done w Aspire NR. The last tranche was a couple weeks ago. Bigger plans and infusion coming from what I believe.
That’s funny! Good morning IPIX. My guess another low volume, no news day! Let’s see if I miss
They are missin 100k
I’ll tell you all...phenomenal P results are not off the table. It for sure has been drilled here over and over that it is impossible! But take a moment and really think and believe, we could potentially see some extraordinary results based on pre-clinical and phase 2a dose dependent response.
Don’t throw your hats in that we are going to be disappointed.
On the other hand maybe it’s good to set expectations at a 25-30% PASI 75.....but not me! I want 40%+ PASI 75.
IPIX! We’ve got the meats!
13.1 billion - starting bid for entire company. ;). That’s if P hits 40% PASI 75
How? It is otherwise because MGMT have not been given P data...it is still blind. While they wait they added several more CDAs and in meetings with potential partners. While they wait they are completing the final report on BOM and meeting with the fda to figure out BTD and next step. While they wait they are negotiating manufacturing of B in mass. While they wait they are in conversations with several possible partners including some CDA BPs on formulation of B for derma uses.
So many positive things are happening!
Oh by the way...while we wait, the next step in K Oral is being completed and we should see a trial guideline soon.
Is me saying 100s of millions in the bank and on Nasdaq more or less ridiculous than people screaming RS?
Let’s find out scotty
No one is selling. Have you seen the volume? Lol. IPIX will be on the Nasdaq soon and have several hundred million in the bank.
BODs will be assigned from BP - watch and learn friends. This is going to be the quickest and smoothest uplist you all will ever be apart of.
I think we will be very happy here soon. Don’t let the painted picture from the moron field get to you. I know it’s hard as I do have some close friends and family who are not used to biotech investing and man do I hear the cry’s sometimes. But here is the truth....this is bio and it will take time. There will be far more lulls than highs due to clinical framework and how damn long it takes just to meet w the fda.
Prurisol is not known, so don’t let them make you think otherwise. The minute Leo knows and has data we will all know.
That’s my take.
IPIX!
“Sounds like P will disappoint”...please provide the link where I can find that! Because all I read is how powerful an oral psoriasis drug can be. All I’ve read is that they found a dose response with 200mg and moved to 300 and 400 to see if it yet has an even better response.
So let me know where I can read that P is going to disappoint.
Good points.